Why You Are Probably Reading This Right Now If you are here, you likely just saw an ad
In 2025, Ozempic was approved by the US Food and Drug Administration (FDA) to reduce the risk of worsening kidney disease and kidney failure in people with type 2 diabetes
If you're ready to explore a new path to weight loss, schedule a consultation with us in Atlanta today
470,478,482,483,484 GLP-1RAs in the digestive system Treatment with GLP-1RAs can alleviate insulin signaling by reducing the phosphorylation of Akt protein (Decreased Akt-P) and activating Protein Kinase C- (PKC-)
An increased intestinal absorption of bile acids stimulates the secretion of FGF19 from intestinal enterocytes (26), and increasing circulating levels of both bile acids and FGF19 inhibit hepatic bile acid synthesis, as mentioned above
Meal timing and composition matter considerably when taking GLP-1 medications